Transforming growth factor-β1-induced expression of connective tissue growth factor is enhanced in bronchial fibroblasts derived from asthmatic patients

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 7-8, 2012, Pages 326-332

  Wójcik, Katarzyna A ^a   Koczurkiewicz, Paulina ^a   Michalik, Marta ^a   Sanak, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Airway wall remodeling; Asthma; Connective tissue growth factor; Wnt signaling pathway

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEIN;

ARTICLE; ASTHMA; BRONCHIAL FIBROBLAST; BRONCHUS BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROBLAST; MALE; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY;

EID: 84866063473     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1343     Document Type: Article

References (26)

1. Makinde T, Murphy RF, Agrawal DK. The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol. 2007; 85: 348-356.
2. Powell DW, Mifflin RC, Valentich JD, et al. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol. 1999; 277: C1-9.
3. Hinz B, Phan SH, Thannickal VJ, et al. The myofibroblast: one function, multiple origins. Am J Pathol. 2007; 170: 1807-1816.
4. Batra V, Musani AI, Hastie AT, et al. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy. 2004; 34: 437-444.
5. Doherty T, Broide D. Cytokines and growth factors in airway remodeling in asthma. Curr Opin Immunol. 2007; 19: 676-680.
6. Redington AE, Madden J, Frew AJ, et al. Transforming growth factor?beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med. 1997; 156: 642-647.
7. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol. 2007; 127: 526-537.
8. Michalik M, Pierzchalska M, Włodarczyk A, et al. Transition of asthmatic bronchial fibroblasts to myofibroblasts is inhibited by cell-cell contacts. Respir Med. 2011; 105: 1467-1475.
9. Leask A, Holmes A, Abraham DJ. Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep. 2002; 4: 136-142.
10. Sato S, Nagaoka T, Hasegawa M, et al. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol. 2000; 27: 149-154.
11. Leask A, Denton CP, Abraham DJ. Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J Invest Dermatol. 2004; 122: 1-6.
12. Michalik M, Pierzchalska M, Legutko A, et al. Asthmatic bronchial fibroblasts demonstrate enhanced potential to differentiate into myofibroblasts in culture. Med Sci Monit. 2009; 15: BR194?201.
13. GINA Report: Global strategy for asthma management and prevention. Updated 2009. Global Initiative for Asthma. http://www.ginasthma.org. Accessed February 22, 2010.
14. Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol. 2002; 14: 681-685.
15. Abraham D. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc? Rheumatology (Oxford). 2008; 47: v8-9.
16. Phanish MK, Winn SK, Dockrell ME. Connective tissue growth factor- (CTGF, CCN2) - a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol. 2010; 114: e83-92.
17. Leask A, Parapuram SK, Shi-Wen X, Abraham DJ. Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? J Cell Commun Signal. 2009; 3: 89-94.
18. Kular L, Pakradouni J, Kitabgi P, et al. The CCN family: a new class of inflammation modulators? Biochimie. 2011; 93: 377-388.
19. Kono M, Nakamura Y, Suda T, et al. Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF). Clin Chim Acta. 2011; 412: 2211-2215.
20. Burgess JK. Connective tissue growth factor: a role in airway remodelling in asthma? Clin Exp Pharmacol Physiol. 2005; 32: 988-994.
21. Burgess JK. The role of the extracellular matrix and specific growth factors in the regulation of inflammation and remodelling in asthma. Pharmacol Ther. 2009; 122: 19-29.
22. Burgess JK, Johnson PR, Ge Q, et al. Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med. 2003; 167: 71-77.
23. Xie S, Sukkar MB, Issa R, et al. Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2005; 288: L68-76.
24. Leask A. Possible strategies for anti-fibrotic drug intervention in scleroderma. J Cell Commun Signal. 2011; 5: 125-129.
25. Chen Y, Segarini P, Raoufi F, et al. Connective tissue growth factor is secreted through the Golgi and is degraded in the endosome. Exp Cell Res. 2001; 271: 109-117.
26. Chen Y, Abraham DJ, Shi-Wen X, et al. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell. 2004; 15: 5635-5646.